OSSIFY Trademark

Trademark Overview


On Friday, August 2, 2024, a trademark application was filed for OSSIFY with the United States Patent and Trademark Office. The USPTO has given the OSSIFY trademark a serial number of 98680340. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, February 24, 2025. This trademark is owned by Surgical Esthetics Biomedical Technologies. The OSSIFY trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft bone and tissue
ossify

General Information


Serial Number98680340
Word MarkOSSIFY
Filing DateFriday, August 2, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, February 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesHuman allograft bone and tissue

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 2, 2024
Primary Code005
First Use Anywhere DateMonday, July 1, 2013
First Use In Commerce DateMonday, July 1, 2013

Trademark Owner History


Party NameSurgical Esthetics Biomedical Technologies
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorthridge, CA 91324

Trademark Events


Event DateEvent Description
Friday, August 2, 2024NEW APPLICATION ENTERED
Thursday, January 16, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 24, 2025NON-FINAL ACTION WRITTEN
Monday, February 24, 2025NON-FINAL ACTION E-MAILED
Monday, February 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 10, 2025ASSIGNED TO EXAMINER

Related Keywords


ossify tissue bone allograft human